Search research articles
Contact Us
Filters
Showing results (1-10 of 78) with videos related to
Page
of 8
Sort By:
Future Oncology (London, England)
|
February 25, 2021
Immune dysfunction, minimal residual disease and patient outcome in nonmetastatic cancer: could modulation of immune function improve outcome?
Nigel P Murray
The Journal of Urology
|
November 27, 2019
Editorial Comment
Nigel P Murray
Advances in Clinical Chemistry
|
March 21, 2024
Biomarkers of minimal residual disease and treatment
Nigel P Murray
Biomarkers in Medicine
|
October 22, 2019
Biomarkers detecting minimal residual disease in solid tumors: what do they mean in the clinical management of patients?
Nigel P Murray
Cureus
|
February 1, 2018
Treatment of Minimal Residual Disease in Breast Cancer: A Longitudinal Case Study
Nigel P Murray
Biological Research
|
September 6, 2018
Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management
Nigel P Murray
International Journal of Molecular Sciences
|
December 11, 2025
Minimal Residual Disease in Breast Cancer: Tumour Microenvironment Interactions, Detection Methods and Therapeutic Approaches
Nigel P Murray, Socrates Aedo
Case Reports in Urology
|
August 25, 2012
Hypernephroma presenting with cutaneous leukocytoclastic vasculitis and lupus anticoagulant: resolution after nephrectomy
Nigel P Murray, Amparo Ruíz, Eduardo Reyes
Case Reports in Gastrointestinal Medicine
|
September 12, 2012
Duodenal tumor presenting as acquired hemophilia in an 88-year-old woman: a clinical case and review of the literature
Nigel P Murray, Juan Carlos Moncada, Marcelo Moran
Hematology, Transfusion and Cell Therapy
|
September 13, 2021
Transient acquired factor XII deficiency associated with moderately severe Covid-19 pneumonia
Nigel P Murray, Eghon Guzman, Monica Del Prado
Page
of 8
Search research articles
Search
Showing results (1-10 of 78) with videos related to
Sort By:
Page
of 8
Future Oncology (London, England)
|
February 25, 2021
Immune dysfunction, minimal residual disease and patient outcome in nonmetastatic cancer: could modulation of immune function improve outcome?
Nigel P Murray
The Journal of Urology
|
November 27, 2019
Editorial Comment
Nigel P Murray
Advances in Clinical Chemistry
|
March 21, 2024
Biomarkers of minimal residual disease and treatment
Nigel P Murray
Biomarkers in Medicine
|
October 22, 2019
Biomarkers detecting minimal residual disease in solid tumors: what do they mean in the clinical management of patients?
Nigel P Murray
Cureus
|
February 1, 2018
Treatment of Minimal Residual Disease in Breast Cancer: A Longitudinal Case Study
Nigel P Murray
Biological Research
|
September 6, 2018
Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management
Nigel P Murray
International Journal of Molecular Sciences
|
December 11, 2025
Minimal Residual Disease in Breast Cancer: Tumour Microenvironment Interactions, Detection Methods and Therapeutic Approaches
Nigel P Murray, Socrates Aedo
Case Reports in Urology
|
August 25, 2012
Hypernephroma presenting with cutaneous leukocytoclastic vasculitis and lupus anticoagulant: resolution after nephrectomy
Nigel P Murray, Amparo Ruíz, Eduardo Reyes
Case Reports in Gastrointestinal Medicine
|
September 12, 2012
Duodenal tumor presenting as acquired hemophilia in an 88-year-old woman: a clinical case and review of the literature
Nigel P Murray, Juan Carlos Moncada, Marcelo Moran
Hematology, Transfusion and Cell Therapy
|
September 13, 2021
Transient acquired factor XII deficiency associated with moderately severe Covid-19 pneumonia
Nigel P Murray, Eghon Guzman, Monica Del Prado
Page
of 8